PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
AKT2 873 Target Target Acetyl-Coa Carboxylase 1 118 1 0.00 -1.00 0.01 0.67
AKT2 873 Target Disease Chronic Lymphocytic Leukemia 11,642 2 0.00 -1.00 0.00 0.57
AKT2 873 Target Disease Salivary Gland Cancer 202 1 0.00 -1.00 0.00 0.66
AKT2 873 Target Target ERK2 3,287 4 0.00 -1.00 0.00 0.63
AKT2 873 Target Disease Diabetic Nephropathy 12,496 1 0.00 -1.00 0.00 0.55
AKT2 873 Target Disease Arthritis 128,324 2 0.00 -1.00 0.00 0.51
AKT2 873 Target Target DAPK1 205 1 0.00 -1.00 0.00 0.66
AKT2 873 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.00 0.56
AKT2 873 Target Disease Shock 134,031 11 0.00 -0.99 0.01 0.55
AKT2 873 Target Disease Rheumatoid Arthritis 78,952 2 0.00 -1.00 0.00 0.52
AKT2 873 Target Disease Cholesterol 182,390 10 0.00 -0.99 0.01 0.54
AKT2 873 Target Target Collagen 138,882 10 0.00 -0.99 0.01 0.55
AKT2 873 Target Disease Neutropenia 25,934 1 0.00 -1.00 0.00 0.53
AKT2 873 Target Target Cox-2 21,583 1 0.00 -1.00 0.00 0.54
AKT3 293 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.58
AKT3 293 Target Disease Brain Tumors 16,749 1 0.00 -1.00 0.00 0.57
AKT3 293 Target Target ERBB3 1,154 3 0.01 -0.99 0.01 0.68
AKT3 293 Target Target BRAF 4,766 8 0.01 -0.99 0.03 0.67
AKT3 293 Target Disease Lung Cancer 91,416 9 0.00 -0.98 0.03 0.58
AKT3 293 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.00 0.54
AKT3 293 Target Target Glutathione S-Transferase Mu 2 8 1 0.02 -0.93 0.12 0.74
AKT3 293 Target Disease Inflammation 252,734 6 0.00 -0.99 0.02 0.54
AKT3 293 Target Drug Doxorubicin 28,033 3 0.00 -0.99 0.01 0.58
AKT3 293 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.00 0.58
AKT3 293 Target Disease Glioblastoma 17,933 6 0.00 -0.99 0.02 0.61
AKT3 293 Target Disease Seizures 66,465 5 0.00 -0.99 0.02 0.57
AKT3 293 Target Disease Leukemia 162,805 6 0.00 -0.99 0.02 0.56
AKT3 293 Target Disease Multiple Myeloma 24,594 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Breast Cancer 173,695 28 0.00 -0.95 0.10 0.59
AKT3 293 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.00 0.53
AKT3 293 Target Disease Cholesterol 182,390 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Target Collagen 138,882 6 0.00 -0.99 0.02 0.56
AKT3 293 Target Disease Hepatitis 163,842 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Disease Pain 409,851 1 0.00 -1.00 0.00 0.50
AKT3 293 Target Disease Epilepsy 71,172 4 0.00 -0.99 0.01 0.57
AKT3 293 Target Target APOE 12,771 1 0.00 -1.00 0.00 0.57
AKT3 293 Target Target ERK2 3,287 2 0.00 -1.00 0.01 0.63
AKT3 293 Target Target Urokinase-Type Plasminogen Activator 3,939 1 0.00 -1.00 0.00 0.61
AKT3 293 Target Target CCL2 3,560 1 0.00 -1.00 0.00 0.61
AKT3 293 Target Disease Arthritis 128,324 1 0.00 -1.00 0.00 0.52
AKT3 293 Target Target Cox-2 21,583 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Target EGF 27,487 8 0.00 -0.99 0.03 0.61
AKT3 293 Target Disease Salivary Gland Cancer 202 1 0.00 -1.00 0.00 0.70
AKT3 293 Target Disease Amyotrophic Lateral Sclerosis 14,006 3 0.00 -0.99 0.01 0.60
AKT3 293 Target Disease Shock 134,031 3 0.00 -0.99 0.01 0.54
AKT3 293 Target Target ERK1 18,374 4 0.00 -0.99 0.01 0.60
AKT3 293 Target Target ETS1 539 1 0.00 -1.00 0.00 0.67
AKT3 293 Target Target ANGPTL4 289 1 0.00 -1.00 0.00 0.69
AKT3 293 Target Disease Autism 20,962 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Sarcoidosis 19,176 1 0.00 -1.00 0.00 0.56
ALK Phos 19 Target Target CD146 729 1 0.01 -0.97 0.05 0.70
ALK Phos 19 Target Disease Cholesterol 182,390 3 0.00 -0.92 0.16 0.58
ALK Phos 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
ALK Phos 19 Target Disease Hepatitis 163,842 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
ALK Phos 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Skin Rash 3,684 1 0.00 -0.97 0.05 0.65
ALK Phos 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
ALK Phos 19 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.05 0.59
ALPP 80 Target Target Collagen 138,882 2 0.00 -0.99 0.03 0.56
ALPP 80 Target Disease Menopause 19,680 1 0.00 -0.99 0.01 0.59
ALPP 80 Target Disease Infertility 35,448 1 0.00 -0.99 0.01 0.57
ALPP 80 Target Disease Pain 409,851 2 0.00 -0.99 0.03 0.53
ALPP 80 Target Disease Disabilities 28,757 1 0.00 -0.99 0.01 0.58
AMAC-1 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
AMAC-1 19 Target Target Eotaxin 2,457 1 0.00 -0.97 0.05 0.66
AMAC-1 19 Target Target DC-CK1 22 4 0.20 -0.80 0.21 0.90
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Target CD14 9,941 1 0.00 -0.97 0.05 0.63
AMAC-1 19 Target Disease Osteoarthritis 36,287 1 0.00 -0.97 0.05 0.60
AMAC-1 19 Target Disease Cancer 1,053,491 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
AMAC-1 19 Target Disease Septic Arthritis 4,121 1 0.00 -0.97 0.05 0.65
AMAC-1 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
AMAC-1 19 Target Target CCL3 1,427 1 0.01 -0.97 0.05 0.68
AMAC-1 19 Target Target CCL4 5,638 1 0.00 -0.97 0.05 0.64
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
AMAC-1 19 Target Disease Arthritis 128,324 1 0.00 -0.97 0.05 0.57
AMAC-1 19 Target Target CCL2 3,560 1 0.00 -0.97 0.05 0.65
AMBP 160 Target Target A1AT 329 1 0.00 -1.00 0.01 0.70
AMBP 160 Target Disease Headache 50,687 1 0.00 -1.00 0.01 0.55
AMBP 160 Target Disease Major Depressive Disorder 12,517 1 0.00 -1.00 0.01 0.59
AMBP 160 Target Disease Hypotension 42,123 2 0.00 -0.99 0.01 0.57
AMBP 160 Target Target APOA1 958 1 0.00 -1.00 0.01 0.66
AMBP 160 Target Disease Arrhythmia 29,330 1 0.00 -1.00 0.01 0.56
AMBP 160 Target Disease Albuminuria 6,831 5 0.00 -0.98 0.03 0.65
AMBP 160 Target Disease Anemia 81,663 1 0.00 -1.00 0.01 0.54
AMBP 160 Target Disease Diabetes Mellitus Type 2 1,311 1 0.00 -1.00 0.01 0.65
AMBP 160 Target Disease Non Insulin Dependent Diabetes Mellitus 6,686 2 0.00 -0.99 0.01 0.62
AMBP 160 Target Target A1M 59 2 0.02 -0.98 0.03 0.77
AMBP 160 Target Disease Tuberculosis 146,217 1 0.00 -1.00 0.01 0.53
AMBP 160 Target Disease Infection 766,637 5 0.00 -0.98 0.03 0.53
AMBP 160 Target Disease Bladder Cancer 21,509 1 0.00 -1.00 0.01 0.57
AMBP 160 Target Disease Stroke 146,992 8 0.00 -0.97 0.05 0.58
AMBP 160 Target Target B2M 677 1 0.00 -1.00 0.01 0.67
AMBP 160 Target Disease Glomerulonephritis 23,459 1 0.00 -1.00 0.01 0.57
AMBP 160 Target Target ERK1 18,374 1 0.00 -1.00 0.01 0.58
AMBP 160 Target Disease Diabetic Nephropathy 12,496 5 0.00 -0.98 0.03 0.63
AMBP 160 Target Disease Renal Failure 73,993 2 0.00 -0.99 0.01 0.56
AMBP 160 Target Target AFP 9,751 1 0.00 -1.00 0.01 0.59